Decrease in splenic lymphoid chemokines in mice developing Amela-melanomas. by Saïdi M. Soudja (118745)

Oxidation of glycans results in a decreased production of IL-4 and IL-10 and an increase of IFNγ by parasite specific splenocytes. by Ernesto Rodríguez (840670)

MML-induced autophagy is associated with the decrease in p53 levels. by Hyun-Kyu An (498473)

Decreased MUFA/SFA ratio in total lipids of lung cancer cells treated with a small molecule inhibitor of SCD activity. by Natalia Scaglia (370865)

<i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

“…<p>(A) GFP fluorescence of one-day old wild-type (left panel) and <i>roh</i>^{<i>EY04039</i>} (right panel) flies showing a reduction in Rh1-GFP. …”

Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

Loss of nsp14-ExoN activity decreases recombination frequency and alters recombination junction patterns across the genome. by Jennifer Gribble (10005444)

Recombinant SFRP3 decreases migration and invasion of melanoma cells. by Elin J. Ekström (225100)

Telmisartan decreased NO production in LPS-stimulated BV2 and primary neonatal rat glial cells. by Nofar Torika (3169497)

DHEA decreases the apoptotic loss of TrkA positive sensory neurons in dorsal root ganglia of NGF null mouse embryos. by Iakovos Lazaridis (223341)

Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Cancer drugs that decrease cardiomyocyte viability induce cellular stress. by E. Renee Matthews (18071587)

Treatment with anti-JAM-C antibody decreases the T-cell response by Gaby Palmer (636)

miR-200b is sufficient to decrease tumor growth. by LaTanya V. Williams (504683)

“…(G, H) Tumor sections were stained for Ki-67, to evaluate proliferation. Note a significant decrease in Ki-67–positive nuclei in the presence of miR-200b. *, p<0.001.…”

Treatment with rSFRP4 results in decreased Wnt signalling. by Caroline E. Ford (289563)

“…Results represent the average of 3 experiments and bars represent the standard deviation (s.d) of the mean. *<i>P</i><0.05. (<b>B</b>) Representative immunoblots showing increased SFRP4 and decreased nuclear β-catenin protein expression in OVCAR3 cells following 72 hours treatment with rSFRP4 (5 µg/ml). …”

Plakoglobin decreases <i>in vitro</i> cell growth and proliferation. by Zackie Aktary (481667)

Study selection criteria. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PRISMA flow chart. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”